Arthur Fuege Email Address

Head of Information Technology Infrastructure and Operations at Cerevel Therapeutics

PAREXEL International is a multinational, life sciences consulting firm. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process.

Senior Technology Executive who champions innovative solutions to complex issues by implementing new concepts, processes, and technology. ✔ Identifies, develops and implements the IT Infrastructure & Operations strategy and roadmap, aligning it with overall IT and business strategic plans. ✔ Oversees network/data operations, business continuity, and revitalization plans that identify issues and implement corrective solutions. ✔ Experience working with globally distributed and diverse teams to achieve operational targets. ✔ Expertly leads teams across all phases of project deployment, utilizing team-building strategies to maximize motivation, productivity, and performance. ✔ Visionary leader that embraces challenges and cultivates a culture of teamwork and innovation. ✔ Introduces cutting-edge technologies and initiatives that improve productivity, efficiency, and quality of overall operations. ✔Establishes technical standards, ensuring compliance to organizational and regulatory guidelines. Core Competencies: ☑IT Infrastructure Engineering & Operations ☑Security Engineering & Operations ☑IT Service Management & Delivery ☑Data Center & Facilities Operations ☑Vendor Management ☑Business Continuity & Disaster Recovery ☑Mergers, Acquisitions & Divestitures ☑Financial Planning & Budget Management ☑IT Project Governance ☑Program Management ☑IT Portfolio Management ☑Strategic Planning & Execution ☑ Long Range Planning & Technology Roadmap Development ☑Software Engineering & Application Development ☑Systems Integration ☑Cross-Functional Collaboration ☑IT Assessments ☑Risk Mitigation ☑Human Capital Management ☑Team Leadership Currently serving as Head of Information Technology Infrastructure & Operations at Cerevel Therapeutics. Cerevel is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.